Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company was founded in 2018 and is headquartered in Toronto, Canada.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Thiogenesis Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Thiogenesis Therapeutics Corp market cap is $36.3M.
What is the 52-week high for Thiogenesis Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Thiogenesis Therapeutics Corp 52 week high is $2.58 as of October 24, 2025.
What is the 52-week low for Thiogenesis Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Thiogenesis Therapeutics Corp 52 week low is $0.0016 as of October 24, 2025.
What is Thiogenesis Therapeutics Corp stock price today?
Thiogenesis Therapeutics Corp stock price today is $0.5834.
What was Thiogenesis Therapeutics Corp stock price yesterday?
Thiogenesis Therapeutics Corp stock price yesterday was $0.585.
What is the PE ratio of Thiogenesis Therapeutics Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Thiogenesis Therapeutics Corp’s P/E ratio is -7.30.
What is the Price-to-Book ratio of Thiogenesis Therapeutics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Thiogenesis Therapeutics Corp P/B ratio is 80.6916.
What is the 50-day moving average of Thiogenesis Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Thiogenesis Therapeutics Corp 50-day moving average is $0.5837.
